GSK, Alphabet Join Forces With $712M Bioelectronics Venture
U.K.-based GlaxoSmithKline and the life sciences unit of Alphabet, Google's parent company, unveiled plans Monday to invest up to £540 million ($711.7 million) into a joint venture that will focus on...To view the full article, register now.
Already a subscriber? Click here to view full article